参考文献

［1］DÜNDAR Y，BOLAND A，STROBL J，et al.Newer hypnotic drugs for the short-term management of insomnia:a systematic review and economic evaluation.Health Technol Assess，2004，8（24）:iii-x，1-125.

［2］SADOCK B J，SADOCK V A，RUIZ P.Kaplan & Sadock's concise textbook of clinical psychiatry.4th ed.Philadelphia:Wolters Kluwer，2017.

［3］KAUFMANN C N，SPIRA A P，ALEXANDER G C，et al.Trends in prescribing of sedative-hypnotic medications in the USA:1993-2010.Pharmacoepidemiology and drug safety，2016，25（6）:637-645.

［4］OLFSON M，KING M，SCHOENBAUM M.Benzodiazepine use in the United States.JAMA Psychiatry，2015，72（2）:136-142.

［5］Center for Behavioral Health Statistics and Quality.（2019）.MD:www.samhsa.gov.

［6］Report of the International Narcotics Control Board for 2020.（2020）.MD:www.incb.org.

［7］阎媛媛，刘屏，刘皈阳.解放军总医院门诊处方中苯二氮 类药物使用调查.药物流行病学杂志，1997，6（4）:226-227，262.

［8］齐妍，黎云燕，王国栋，等.2007—2012年天津医科大学第二医院口服镇静催眠药应用分析.中国医院用药评价与分析，2013，13（4）:316-319.

［9］周义湘，陈雪丽，黄颖华.精神专科医院2015～2017年门诊第二类精神药品利用分析与评价.中国现代医生，2019，57（1）:36-39.

［10］黎彪，石淑亚.精神病专科医院300例住院患者中应用苯二氮 类药物情况分析.北方药学，2016，13（6）:171-172.

［11］王文哲.精神专科医院镇静催眠药的处方调查.上海：上海交通大学医学院，2020.

［12］HSIAO F Y，HSIEH P H，GAU C S.Ten-year trend in prescriptions of z-hypnotics among the elderly:a nationwide，cross-sectional study in Taiwan.Journal of clinical gerontology and geriatrics，2012，4（2）:37-41.

［13］National Institute for Clinical Excellence.Technology Appraisal Guidance 77.Guidance on the use of zaleplon，zolpidem and zopiclone for the short-term management of insomnia，2009.

［14］BUSCEMI N，VANDERMEER B，FRIESEN C，et al.Manifestations and management of chronic insomnia in adults.Evidence report/technology assessment:issue 125，2015:1-10.

［15］BANDELOW B，REITT M，RÖVER C，et al.Efficacy of treatments for anxiety disorders:a meta-analysis.International clinical psychopharmacology，2015，30（4）:183-192.

［16］FICK D，SEMLA T，BEIZER J，et al.American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.Journal of the American Geriatrics Society，2012，60（4）:616-631.

［17］ASHTON H.The diagnosis and management of benzodiazepine dependence.Current opinion in psychiatry，2005，18（3）:249-255.

［18］MAUST D T，LIN L A，BLOW F C.Benzodiazepine use and misuse among adults in the United States.Psychiatric services，2019，70（2）:97-106.

［19］U.S.FDA.FDA expands Boxed Warning to improve safe use of benzodiazepine drug（https://www.fda.gov/drugs/drug-safety-andavailability/fda-requiring-boxed-warning-updated-improve-safe-usebenzodiazepine-drug-class）.，2020.

［20］熊娜娜，骆蕾，孙伟，等.Z类药物滥用和依赖风险的研究进展.中国药物依赖性杂志，2020，29（6）:401-405，429.

［21］College of Physicians and Surgeons of British Columbia.Safe prescribing of drugs with potential for misuse/diversion（https://www.cpsbc.ca/files/pdf/PSG-Safe-Prescribing.pdf）.Professional standards and guidelines，2017.

［22］NIR T，AMICHAI P，LITAL K G，et al.Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis.Age and ageing，2018，47（2）:201-208.

［23］CHITTARANJAN A.Sedative hypnotics and the risk of falls and fractures in the elderly.Journal of clinical psychiatry，2018，79（3）:18f12340.

［24］NICOLE R，REBECCA R.Z-drugs and falls:a focused review of the literature.Senior care pharmacist，2020，35（12）:549-554.

［25］BRANDT J，LEONG C.Benzodiazepines and Z-drugs:an updated review of major adverse outcomes reported on in epidemiologic research.Drugs in R&D，2017，17（4）:493-507.

［26］KRIPKE D F.Mortality risk of hypnotics:strengths and limits of evidence.Drug safety，2016，39（2）:93-107.

［27］PENNINKILAMPI R，ESLICK G D.A systematic review and metaanalysis of the risk of dementia associated with benzodiazepine use，after controlling for protopathic bias.CNS drugs，2018，32（6）:485-497.

［28］LUCCHETTA R C，DA MATA B P M，MASTROIANNI DE P C.Association between development of dementia and use of benzodiazepines:a systematic review and meta-analysis.Pharmacotherapy，2018，38（10）:1010-1020.

［29］GRAY S L，DUBLIN S，YU O，et al.Benzodiazepine use and risk of incident dementia or cognitive decline:prospective population based study.The BMJ，2016，352:i90.

［30］OSLER M，JØRGENSEN M B.Associations of benzodiazepines，Z-Drugs，and other anxiolytics with subsequent dementia in patients with affective disorders:a nationwide cohort and nested case-control study.The American journal of psychiatry，2020，177（6）:497-505.

［31］ROSENBAUM J F.Benzodiazepines:a perspective.The American journal of psychiatry，2020，177（6）:488-490.

［32］KIM H B，MYUNG S K，PARK Y C，et al.Use of benzodiazepine and risk of cancer:a meta-analysis of observational studies.International journal of cancer，2017，140（3）:513-525.

［33］KIM D H，KIM H B，KIM Y H，et al.Use of hypnotics and risk of cancer:a meta-analysis of observational studies.Korean journal of family medicine，2018，9（4）:211-218.

［34］PENG T R，YANG L J，WU T W，et al.Hypnotics and risk of cancer:a meta-analysis of observational studies.Medicina，2020，56（10）:513. FZTvfvpx/fTGt2iM6UwqIbquJU72Nq683//yj4RGWmKydZen0DMQLMkcBEOVT/vz